Abstract
The clinical association of essential hypertension with metabolic abnormalities, such as hyperinsulinemia, insulin resistance, obesity, altered glucose tolerance and/or frank non-insulin dependent diabetes mellitus (NIDDM) has long been appreciated(1). Each of the above clinical conditions is extremely frequent in the elderly. The association of these different clinical states, that is also common at younger ages, has been termed “Syndrome X” and more recently “Generalized Cardiovascular-Metabolic Disease.”(2,3) Although several hypothesis have been proposed, including a primary role of hyperinsulinemia and insulin resistance, the mechanism(s) of this linkage has not been established. This syndrome complex is frequently associated with target organ involvement, such as left ventricular hypertrophy (LVH) and atherosclerosis of the coronary and peripheral vascular beds.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Jarret RJ, Keen H, McCartney M, Fuller JH, Hamilton PJS, Reid D, Rose G.: Glucose tolerance and blood pressure in two population samples. Their relationship to diabetes mellitus and hypertension. Am.J.Epidemiol., 1978, 7: 15–24.
Resnick LM: Ionic basis of hypertension, insulin resistance, vascular disease and related disorders. The mechanism of “Syndrome X”. Am.J.Hypertens., 1993, 6: 123S–134S.
Barbagallo M., Resnick LM, Calcium and Magnesium in the regulation of smooth muscle function and blood pressure. in: Endocrinology of the Vasculature, JR Sowers editor, Humana Press Inc. NJ, USA, pp. 283-300.
Ringer S.: A third contribution regarding the infusion of the inorganic constituents of the blood on the ventricular contraction. J.Physiol., 1883, 222-5.
Kuriyama H., Uishi I., Suaky H., Kitamura K., Itoh T.: Factors modifying contraction-relaxation in vascular smooth muscle. Am.J.Physiol., 1982, 243: H641–H662.
Borle AB: Control, modulation and regulation of cell calcium. Rev. Physiol. Biochem. Pharmacol., 1981, 90:13–153.
Rasmussen H.: Calcium messenger system. N.Engl.J.Med., 1986, 314:1094–1107, 1164-1170.
Eggermont J.A., Vrolix M., Raeymaekers L., Wuytack F., Casteels R.: Ca++ transport ATPases of vascular smooth muscle. Circ.Res., 1988, 62: 266–278.
Nabel E.G., Berk B.C., Brock T.A., Smith T.W: Na+-Ca++ exchange in cultured vascular smooth muscle cells. Circ.Res., 1988, 62: 486–489.
Rubin RP: The role of calcium in the release of neurotransmitter substances and hormones. Pharmacol. Rev. 1970; 22: 389–427.
Altura BM, Altura BT: Magnesium ions and contractions on vascular smooth muscles: relationship to some vascular diseases. Fed Proc. 1981; 40: 2672–79.
Altura BM, Altura BT, Carella A, Turlapaty PDMV: Ca++ coupling in vascular smooth muscle: Mg++ and buffer effects on contractility and membrane Ca++ movements. Can.J.Physiol. 1982; 60: 459–482.
Altura BM, Altura BT: Magnesium and contractions of arterial smooth muscle. Microvasc Res. 1974; 7: 145–155.
Woods WT, Katholi RE, Urthaler F, James TN: Electrophysiological effects of magnesium on cells in the canine sinus node and false tendon. Circ. Res. 1979; 44: 182–188.
Turlapaty PDMV, Altura BM: Extracellular magnesium ions control calcium exchange and content of vascular smooth muscle. Eur J Pharmacol. 1978; 52: 421–23.
Agus ZA, Kalipourie E, Dukes I, Morad M.: Cytosolic magnesium modulates calcium channel activity in mammalian ventricular cells. Am.J.Physiol. 1989; 256: C452–455.
Ji BH, Erne P, Kiosky W, Buhler FR, Bolli P.: Magnesium-induced vasodilatation is comparable to that induced by calcium channel blockade. J.Hypertension 1983; 1(suppl.2): 368–71.
Altura BM, Altura BT.: Role of magnesium ions in contractility of blood vessels and skeletal muscle. Magnesium Bull. 1981; 3: 102–114.
Altura BM, Altura BT, Gebrewold A, Ising H, Guntter T: Magnesium deficiency and hypertension: correlation between magnesium deficient diets and microcircolatory changes in situ. Science 1984; 223: 1315–17.
Paolisso G, Barbagallo M., Hypertension, Diabetes Mellitus and Insulin Resistance. The role of intracellular magnesium. Am.J. Hypertens., 1997, 10, 346–355.
Erne P., Bolli P., Burgissen E., Buhler F.: Correlation of platelets calcium with blood pressure: Effects of antihypertensive therapy. N.Engl.J.Med., 1984, 319: 1084–8.
Resnick L.M., Gupta R.K., Bhargava K.K., Gruenspan H., Alderman M.H., Laragh J.H.: Cellular ions in hypertension, diabetes, and obesity: A nuclear magnetic resonance spectroscopic study. Hypertension, 1991, 17:951–957.
Resnick LM, Gupta RK Sosa RE Corbett ML, Laragh JH. Intracellular free magnesium in erythrocyte of essential hypertension. Proc.Nat.Acad.Sci. USA, 1987, 84: 7663–7667.
Barbagallo M., Gupta RK, Resnick LM. Cellularions in NIDDM: Relation of calcium to hyperglycemia and cardiac mass. Diabetes Care, 1996, 19, 1393–1398.
Resnick L.M., Gupta R.K., Gruenspan H., Alderman M.H., Laragh J.H.: Hypertension and peripheral insulin resistance: mediating role of intracellular free magnesium. Am.J.Hypertens., 1990, 3: 373–379.
Resnick LM, Gupta RK, Di Fabio B, Barbagallo M, Marion R, Laragh JH: Intracellular ionic consequences of dietary salt loading in essential hypertension. J Clin Invest, 1994; 94:1269–76.
Resnick LM, Gupta RK, Gruenspan H., Laragh JH: Intracellular ion response to glucose tolerance: Relation of hypertension, obesity and insulin resistance. Circulation, 1988, 78(suppl.II): 11–570.
Resnick L.M., Barbagallo M., Gupta R.K., Laragh J.H.: Ionic basis of hypertension in diabetes mellitus: role of hyperglycemia. Am.J.Hypertens., 1993, 6: 413–417.
Barbagallo M., Shan J., Pang PKT, Resnick LM: Glucose-induced alterations of cytosolic free calcium in cultured rat tail artery vascular smooth muscle cells. J.Clin.Invest., 1995, 95: 763–767.
Davis FB, Davis PJ, Gerard N, Blas S, MacGillivray S, Gutman S, Feldman J.: The effect of in vivo glucose administration on human Ca-ATPase activity and on enzyme responsiveness in vitro to thyroid hormone and calmodulin. Diabetes, 1985, 34: 639–646.
Deziel MR, Safeer RS, Blas S, Davis FB, Davis PJ: Hexose-specific inhibition in vitro of human red cell Ca++-ATPase-ATP-ase activity. Biochem.Biophys.Acta, 1992, 1110: 119–122.
Draznin B., Leitner W., Sussman KE, Sherman N.: Insulin and glucose modulate protein kinase C in rat adipocytes. Biochem.Biophys.Res.Commun., 1988, 156: 570–575.
Haffner SM, Fong D, Hazude HP, Pugh J.A, Patterson J.K: Hyperinsulinemia, upper body adiposity and cardiovascular risk factors in non diabetics. Metabolism, 1988, 37, 338–345.
Lucas C.P., Estigarribie J.A., Darza L.L., Reaven G.M.: Insulin and blood pressure in obesity and hypertension. Hypertension, 1985, 7, 702–706.
Reaven G.M., Hoffman B.B.: A role for insulin in the aetiology and course of hypertension. Lancet, 1987, 2, 435–437.
Ferrannini E., Buzzigoli G., Bonadonna R., Giorico M.A., Oleggini M., Graziadei L., Pedrinelli R., Brandi L., Bevilacqua S.: Insulin resistance in essential hypertension. N.Engl.J.Med., 1987, 317, 350–357.
Mathias C.J., daCosta D.F., Fosbraey P., Christensen N.J., Bannister R.: Hypotensive and sedative effect of insulin in autonomic nervous failure. Br.Med.J., 1987, 295, 161–163.
Barbagallo M., Gupta R.K., Resnick LM.: Cellular ionic effects of insulin in normal human red cells: a nuclear magnetic resonance study. Diabetologia, 1993, 36: 146–149.
Draznin B., Sussman K.E., Eckel R., Kao M., Yost T., Sherman N.A.: Possible role of cytosolic free calcium concentration in mediating insulin resistance of obesity and hyperinsulinemia. J.Clin.Invest., 1988, 82: 1848–1852
Hoffman J.M., Ishizuka T., Farese R.V.: Interrelated effects of insulin and glucose on diacylglycerol-protein kinase-C signaling in rat adipocytes and soley muscle in vitro and in vivo in diabetic rats. Endocrinology, 128, 2937–2948, 1991.
Paolisso G., Sgambato S., Passariello N., Giugliano D., Scheen AJ., D’Onofrio F., Lefebvre PJ.: Insulin induces opposite changes in plasma and erythrocyte magnesium concentration in normal man. Diabetologia 1986; 29:644–647.
Barbagallo M., Gupta RK, Bardicef M, Bardicef O., Resnick LM: Altered ionic effect of insulin in hypertension: Role of basal ion levels in determining insulin responsiveness. J.Clin.Endocrinol.Metab., 1997, 82, 1761–1765.
Dominguez LJ, Davidoff AJ, Srinivas PR, Standley PR, Walsh MF, Sowers JR: Effects of metformin on tyrosine-kinase activity, glucose transport and intracellular calcium in rat vascular smooth muscle. Endocrinology, 1996, 137, 113–121.
Zhang F., Sowers JR, Ram JL, Standley PR, Peuler JD.: Effect of pioglitazone on L-type calcium channel in vascular smooth muscle. Hypertension, 1994, 24, 170–175.
Song J., Walsh MF, Igwe R, Ram JL, Barazi M, Dominguez LJ, Sowers JR: Trioglitazone reduces contraction by inhibition of vascular smooth muscle cell Ca++ currents and not endothelial nitric oxide production. Diabetes, 1997, 46, 659–664.
Shan J., Resnick LM, Liu Q, Wu X, Barbagallo M, Pang PKT: Vascular effect of 17 estradiol in male SD rats. Am.J.Physiol, 1994; 266:H967–H973.
Barbagallo M, Shan J, Pang PKT, Resnick LM: Vascular effects of progesterone: role intracellular calcium metabolism. Am J Hypertens, 1995;8(part2):66A.
Orentreich N, Brind JL, Rizer RL, Vogelamn JH: Age changes and sex differences in serum dehydroepian-drosterone sulfate concentrations throughout adulthood. J Clin Endocrinol Metab, 1984; 59:551–555.
Yamaji T, Ibayashi H: Plasma dehydroepiandrosterone sulfate in normal and pathological conditions. J Clin Endocrinol Metab, 1969; 29:273–78.
Marmoston J, Griffith GC, Geller PJ, Fishman EL, Welsch F, Weiner JM: Urinary steroids in the measurement of aging and atherosclerosis. J Am Geriat Soc, 1975; 23:481–492.
Barret-Connor E, Khaw KT, Yen SSC: A prospective study of dehydroepiandrosterone sulfate, mortality and cardiovascular disease. N Engl J Med, 1986; 315:1519–24.
Gordon GB, Bush DE, Weishman HF: Reduction of atherosclerosis by administration of dehydroepiandrosterone. J Clin Invest, 1988; 82:712–720.
Barbagallo M, Shan J, Pang PKT, Resnick LM: DHEAS effects on VSMC cytosolic free calcium and vascular contractility. Hypertension, 1995; 26(part 2): 1065–69.
Gordon T.: Blood pressure of adults by age and sex, USA 1960–62. National Center for Health Statistics, 1964, PHS publication 1000, series 11, n.4.
Kannel W.B.: Blood pressure and the development of cardiovascular disease in the aged. In: Cardiology in Old Age. Caird FL, Dall JLC, Kennedy RD eds. New York, NY, Plenum Press publisher, 1976, 143–175.
Andres R.: Aging and diabetes. Med.Clin.North Am., 1971, 55:835–45.
DeFronzo R.A.: Glucose intolerance and aging. Evidence for tissue insensitivity to insulin. Diabetes, 1979, 28: 1095–1101.
Barbagallo M., Gupta R.K., Resnick L.M. Effect of aging on cellular divalent cations: Relation to hypertension and diabetes. J.Invest. Medicine, 1995, 43, suppl.2: 300A.
Barbagallo M., Dominguez LJ, Putignano E., Barbagallo Sangiorgi G., Resnick LM: Effect of aging on intracellular divalent cation metabolism: a link to the increased incidence of hypertension and non-insulin dependent diabetes mellitus in the elderly? Arch. Gerontol. Geriatr., 1996(suppl 5), pp. 233–238.
Lansing AI, Alex M, Rosenthal TB.: Calcium and elastin in human atherosclerosis. J.Geront., 1973, 5: 112–117.
Elkeles A: A comparative radiological study of calcified atheromas in males and females over 50 years of age. Lancet, 1957, ii: 714–715.
Fleckenstein A., Frey M., Zorn S., Fleckenstein-Grun G.: Experimental basis of long term therapy of arterial hypertension with calcium antagonists. Am.J.Cardiol., 1995, 56: 3H–14H.
Orimo H., Ouchi Y.: The role of calcium and magnesium in the development of atherosclerosis. Experimental and clinical evidence. Ann.NY.Acad.Sci., 1990, 598: 444–57.
Orrenius S, McConkey DJ, Bellomo G., Nicotera P.: Role of Ca++ in toxic cell killing. Trends Pharmacol. Sci., 1989, 10:281–285.
Fujita T.: Aging and calcium. Mineral Electrolyte Metab., 1986, 12: 149–156.
Kachaturian ZS: Hypothesis on the regulation of cytosol calcium concentration and the aging brain. Neuro-biol. Aging, 1987, 8, 345–346.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1998 Springer Science+Business Media New York
About this chapter
Cite this chapter
Barbagallo, M. et al. (1998). The Ionic Hypothesis of Aging. In: Barbagallo, M., Licata, G., Sowers, J.R. (eds) Recent Advances in Geriatrics. Springer, Boston, MA. https://doi.org/10.1007/978-1-4899-1483-5_4
Download citation
DOI: https://doi.org/10.1007/978-1-4899-1483-5_4
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4899-1485-9
Online ISBN: 978-1-4899-1483-5
eBook Packages: Springer Book Archive